logo

ANTX

AN2 Therapeutics·NASDAQ
--
--(--)
--
--(--)

ANTX fundamentals

AN2 Therapeutics (ANTX) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.21 (YoY +56.25%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.21
+56.25%
Report date
Aug 12, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

AN2 Therapeutics (ANTX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

AN2 Therapeutics (ANTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

AN2 Therapeutics (ANTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

AN2 Therapeutics (ANTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does AN2 Therapeutics (ANTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track AN2 Therapeutics (ANTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield